Literature DB >> 24141019

Microglial derived tumor necrosis factor-α drives Alzheimer's disease-related neuronal cell cycle events.

Kiran Bhaskar1, Nicole Maphis2, Guixiang Xu3, Nicholas H Varvel4, Olga N Kokiko-Cochran5, Jason P Weick6, Susan M Staugaitis7, Astrid Cardona8, Richard M Ransohoff9, Karl Herrup10, Bruce T Lamb11.   

Abstract

Massive neuronal loss is a key pathological hallmark of Alzheimer's disease (AD). However, the mechanisms are still unclear. Here we demonstrate that neuroinflammation, cell autonomous to microglia, is capable of inducing neuronal cell cycle events (CCEs), which are toxic for terminally differentiated neurons. First, oligomeric amyloid-beta peptide (AβO)-mediated microglial activation induced neuronal CCEs via the tumor-necrosis factor-α (TNFα) and the c-Jun Kinase (JNK) signaling pathway. Second, adoptive transfer of CD11b+ microglia from AD transgenic mice (R1.40) induced neuronal cyclin D1 expression via TNFα signaling pathway. Third, genetic deficiency of TNFα in R1.40 mice (R1.40-Tnfα(-/-)) failed to induce neuronal CCEs. Finally, the mitotically active neurons spatially co-exist with F4/80+ activated microglia in the human AD brain and that a portion of these neurons are apoptotic. Together our data suggest a cell-autonomous role of microglia, and identify TNFα as the responsible cytokine, in promoting neuronal CCEs in the pathogenesis of AD.
© 2013.

Entities:  

Keywords:  AD; Adoptive transfer; Alzheimer's disease; AβF; AβO; BrdU; Bromodeoxyuridine; CCE; CM; COX2; GFP; IDV; IKKα/β; IL-1β; IL-6; INFγ; IκB kinase α/β; JNK; LPS; MAP2; Microglia; NOS; NSAID; Neuroinflammation; Neuronal cell cycle; PAS; PBS; PCNA; PFA; PI3K; Phosphatidylinositol 3-kinase; ROI; RT; STAT3; Signal transducer and activator of transcription 3; TNF receptor; TNFR; TNFα; TUNEL; Terminal deoxynucleotidyl transferase dUTP nick end labeling; Tumor Necrosis Factor-α; Tumor necrosis factor-α (TNFα); c-Jun Kinase; c-Jun Kinase (JNK); cell cycle events; conditioned media; cyclooxygenase-2; fibrillar amyloid-beta peptide; green fluorescent protein; integrated density value; interferon-γ; interleukin-1β; interleukin-6; lipopolysaccharide; microtubule associated protein-2; nitric oxide synthase; non-steroidal anti-inflammatory drug; oligomeric amyloid-beta peptide; p38 MAPK; p38 mitogen activated protein kinase; paraformaldehyde; phosphate buffered saline; proliferating cell nuclear antigen; protein-A-sepharose; region of interest; room temperature

Mesh:

Substances:

Year:  2013        PMID: 24141019      PMCID: PMC3877710          DOI: 10.1016/j.nbd.2013.10.007

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  89 in total

1.  c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis.

Authors:  Z Han; D L Boyle; L Chang; B Bennett; M Karin; L Yang; A M Manning; G S Firestein
Journal:  J Clin Invest       Date:  2001-07       Impact factor: 14.808

2.  Investigation of association of 13 polymorphisms in eight genes in southeastern African American Alzheimer disease patients as compared to age-matched controls.

Authors:  R T Perry; J S Collins; L E Harrell; R T Acton; R C Go
Journal:  Am J Med Genet       Date:  2001-05-08

3.  Induction of apoptosis and cell cycle arrest by a specific c-Jun NH2-terminal kinase (JNK) inhibitor, SP-600125, in gastrointestinal cancers.

Authors:  Harry Hua-Xiang Xia; Hua He; Ji De Wang; Qing Gu; Marie C M Lin; Bing Zou; Li Fen Yu; Yun Wei Sun; Annie O O Chan; Hsiang Fu Kung; Benjamin Chun-Yu Wong
Journal:  Cancer Lett       Date:  2005-12-07       Impact factor: 8.679

4.  Altered distribution of cell cycle transcriptional regulators during Alzheimer disease.

Authors:  Kelly L Jordan-Sciutto; Latha M Malaiyandi; Robert Bowser
Journal:  J Neuropathol Exp Neurol       Date:  2002-04       Impact factor: 3.685

5.  Expression patterns of retinoblastoma protein in Parkinson disease.

Authors:  Kelly L Jordan-Sciutto; Robert Dorsey; Elisabeth M Chalovich; Robert R Hammond; Cristian L Achim
Journal:  J Neuropathol Exp Neurol       Date:  2003-01       Impact factor: 3.685

6.  Elevated circulating tumor necrosis factor levels in Alzheimer's disease.

Authors:  H Fillit; W H Ding; L Buee; J Kalman; L Altstiel; B Lawlor; G Wolf-Klein
Journal:  Neurosci Lett       Date:  1991-08-19       Impact factor: 3.046

7.  Chemical genetic analysis of the time course of signal transduction by JNK.

Authors:  Juan-Jose Ventura; Anette Hübner; Chao Zhang; Richard A Flavell; Kevan M Shokat; Roger J Davis
Journal:  Mol Cell       Date:  2006-03-03       Impact factor: 17.970

8.  Alpha-MSH peptides inhibit production of nitric oxide and tumor necrosis factor-alpha by microglial cells activated with beta-amyloid and interferon gamma.

Authors:  D Galimberti; P Baron; L Meda; E Prat; E Scarpini; R Delgado; A Catania; J M Lipton; G Scarlato
Journal:  Biochem Biophys Res Commun       Date:  1999-09-16       Impact factor: 3.575

9.  Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.

Authors:  Adam C Naj; Gyungah Jun; Gary W Beecham; Li-San Wang; Badri Narayan Vardarajan; Jacqueline Buros; Paul J Gallins; Joseph D Buxbaum; Gail P Jarvik; Paul K Crane; Eric B Larson; Thomas D Bird; Bradley F Boeve; Neill R Graff-Radford; Philip L De Jager; Denis Evans; Julie A Schneider; Minerva M Carrasquillo; Nilufer Ertekin-Taner; Steven G Younkin; Carlos Cruchaga; John S K Kauwe; Petra Nowotny; Patricia Kramer; John Hardy; Matthew J Huentelman; Amanda J Myers; Michael M Barmada; F Yesim Demirci; Clinton T Baldwin; Robert C Green; Ekaterina Rogaeva; Peter St George-Hyslop; Steven E Arnold; Robert Barber; Thomas Beach; Eileen H Bigio; James D Bowen; Adam Boxer; James R Burke; Nigel J Cairns; Chris S Carlson; Regina M Carney; Steven L Carroll; Helena C Chui; David G Clark; Jason Corneveaux; Carl W Cotman; Jeffrey L Cummings; Charles DeCarli; Steven T DeKosky; Ramon Diaz-Arrastia; Malcolm Dick; Dennis W Dickson; William G Ellis; Kelley M Faber; Kenneth B Fallon; Martin R Farlow; Steven Ferris; Matthew P Frosch; Douglas R Galasko; Mary Ganguli; Marla Gearing; Daniel H Geschwind; Bernardino Ghetti; John R Gilbert; Sid Gilman; Bruno Giordani; Jonathan D Glass; John H Growdon; Ronald L Hamilton; Lindy E Harrell; Elizabeth Head; Lawrence S Honig; Christine M Hulette; Bradley T Hyman; Gregory A Jicha; Lee-Way Jin; Nancy Johnson; Jason Karlawish; Anna Karydas; Jeffrey A Kaye; Ronald Kim; Edward H Koo; Neil W Kowall; James J Lah; Allan I Levey; Andrew P Lieberman; Oscar L Lopez; Wendy J Mack; Daniel C Marson; Frank Martiniuk; Deborah C Mash; Eliezer Masliah; Wayne C McCormick; Susan M McCurry; Andrew N McDavid; Ann C McKee; Marsel Mesulam; Bruce L Miller; Carol A Miller; Joshua W Miller; Joseph E Parisi; Daniel P Perl; Elaine Peskind; Ronald C Petersen; Wayne W Poon; Joseph F Quinn; Ruchita A Rajbhandary; Murray Raskind; Barry Reisberg; John M Ringman; Erik D Roberson; Roger N Rosenberg; Mary Sano; Lon S Schneider; William Seeley; Michael L Shelanski; Michael A Slifer; Charles D Smith; Joshua A Sonnen; Salvatore Spina; Robert A Stern; Rudolph E Tanzi; John Q Trojanowski; Juan C Troncoso; Vivianna M Van Deerlin; Harry V Vinters; Jean Paul Vonsattel; Sandra Weintraub; Kathleen A Welsh-Bohmer; Jennifer Williamson; Randall L Woltjer; Laura B Cantwell; Beth A Dombroski; Duane Beekly; Kathryn L Lunetta; Eden R Martin; M Ilyas Kamboh; Andrew J Saykin; Eric M Reiman; David A Bennett; John C Morris; Thomas J Montine; Alison M Goate; Deborah Blacker; Debby W Tsuang; Hakon Hakonarson; Walter A Kukull; Tatiana M Foroud; Jonathan L Haines; Richard Mayeux; Margaret A Pericak-Vance; Lindsay A Farrer; Gerard D Schellenberg
Journal:  Nat Genet       Date:  2011-04-03       Impact factor: 38.330

10.  Tumor necrosis factor alpha triggers proliferation of adult neural stem cells via IKK/NF-kappaB signaling.

Authors:  Darius Widera; Ilja Mikenberg; Margitta Elvers; Christian Kaltschmidt; Barbara Kaltschmidt
Journal:  BMC Neurosci       Date:  2006-09-20       Impact factor: 3.288

View more
  58 in total

Review 1.  Central nervous system myeloid cells as drug targets: current status and translational challenges.

Authors:  Knut Biber; Thomas Möller; Erik Boddeke; Marco Prinz
Journal:  Nat Rev Drug Discov       Date:  2015-12-04       Impact factor: 84.694

2.  Reactive microglia drive tau pathology and contribute to the spreading of pathological tau in the brain.

Authors:  Nicole Maphis; Guixiang Xu; Olga N Kokiko-Cochran; Shanya Jiang; Astrid Cardona; Richard M Ransohoff; Bruce T Lamb; Kiran Bhaskar
Journal:  Brain       Date:  2015-03-31       Impact factor: 13.501

Review 3.  The neuropathology and cerebrovascular mechanisms of dementia.

Authors:  Limor Raz; Janice Knoefel; Kiran Bhaskar
Journal:  J Cereb Blood Flow Metab       Date:  2016-01       Impact factor: 6.200

4.  Posttranslational modification impact on the mechanism by which amyloid-β induces synaptic dysfunction.

Authors:  Katarzyna M Grochowska; PingAn Yuanxiang; Julia Bär; Rajeev Raman; Gemma Brugal; Giriraj Sahu; Michaela Schweizer; Arthur Bikbaev; Stephan Schilling; Hans-Ulrich Demuth; Michael R Kreutz
Journal:  EMBO Rep       Date:  2017-04-18       Impact factor: 8.807

Review 5.  Microglia in Alzheimer's Disease: Exploring How Genetics and Phenotype Influence Risk.

Authors:  Amanda McQuade; Mathew Blurton-Jones
Journal:  J Mol Biol       Date:  2019-02-07       Impact factor: 5.469

6.  Environmental Enrichment Potently Prevents Microglia-Mediated Neuroinflammation by Human Amyloid β-Protein Oligomers.

Authors:  Huixin Xu; Eilrayna Gelyana; Molly Rajsombath; Ting Yang; Shaomin Li; Dennis Selkoe
Journal:  J Neurosci       Date:  2016-08-31       Impact factor: 6.167

7.  [Protective effect of butylphthalide in a cell model of Alzheimer's disease induced by Aβ25-35 in Neuro 2a cells].

Authors:  Jing-Wen Xie; Yan Zhao; Xia-Lu Feng; Fang-Bo Lin; Jing Luo; Xin Liu; De-Ren Hou
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-09-20

8.  Androgen alleviates neurotoxicity of β-amyloid peptide (Aβ) by promoting microglial clearance of Aβ and inhibiting microglial inflammatory response to Aβ.

Authors:  Peng-Le Yao; Shu Zhuo; Hong Mei; Xiao-Fang Chen; Na Li; Teng-Fei Zhu; Shi-Ting Chen; Ji-Ming Wang; Rui-Xing Hou; Ying-Ying Le
Journal:  CNS Neurosci Ther       Date:  2017-09-20       Impact factor: 5.243

9.  mTOR and neuronal cell cycle reentry: How impaired brain insulin signaling promotes Alzheimer's disease.

Authors:  Andrés Norambuena; Horst Wallrabe; Lloyd McMahon; Antonia Silva; Eric Swanson; Shahzad S Khan; Daniel Baerthlein; Erin Kodis; Salvatore Oddo; James W Mandell; George S Bloom
Journal:  Alzheimers Dement       Date:  2016-09-29       Impact factor: 21.566

Review 10.  Multi-Target Drug Candidates for Multifactorial Alzheimer's Disease: AChE and NMDAR as Molecular Targets.

Authors:  Md Sahab Uddin; Abdullah Al Mamun; Md Tanvir Kabir; Ghulam Md Ashraf; May N Bin-Jumah; Mohamed M Abdel-Daim
Journal:  Mol Neurobiol       Date:  2020-09-15       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.